Quantcast

Latest Ohio State University Comprehensive Cancer Center Stories

2012-02-07 23:20:54

    Some early-stage breast cancers are potentially harmless, but others invade surrounding healthy tissue and become deadly.     This study has identified a small pattern of molecules that highlights important differences between early-stage breast tumors and invasive, deadly ones.     The findings might lead to a way to identify early tumors that will likely become invasive. Researchers have discovered a restricted pattern of molecules that...

102738868
2012-01-26 14:06:59

According to a new study, oral infections with the human papillomavirus (HPV) are more common in men than women. The study, published in the Journal of the American Medical Association, said that while the viruses can be found in saliva, HPV appears to be mostly spread through sex. Study author Maura Gillison, a professor at the Ohio State University Comprehensive Cancer Center said the virus can cause cancers at the back of the throat, tonsils and base of the tongue.  Patients...

2012-01-19 15:06:30

    The most common form of lung cancer inevitably develops resistance to the targeted drug gefitinib.     This study shows how this resistance develops.     The findings suggest a new strategy for treating non-small cell lung cancer. New research published in Nature Medicine indicates that targeted drugs such as gefitinib might more effectively treat non-small cell lung cancer if they could be combined with agents that block certain...

2012-01-03 14:52:35

A new study shows that it is possible to selectively target and block a particular microRNA that is important in liver cancer. The finding might offer a new therapy for this malignancy, which kills an estimated 549,000 people worldwide annually.   The animal study, by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) and at Mayo Clinic, focused on microRNA-221...

2011-12-21 14:59:10

The study shows how normal cells in tumors can enhance the growth of the tumor´s cancer cells after losing an important tumor suppressor gene called Pten.   The findings suggest a new strategy for treating breast cancer by interrupting signals between normal cells and cancer cells in tumors.    A new study published in the journal Nature Cell Biology has discovered how normal cells in tumors can fuel tumor growth.   Led by researchers at the Ohio State...

2011-12-15 16:50:59

A new study has identified a gene mutation that researchers estimate dates back to 11,600 B.C., making it the second oldest human disease mutation yet discovered.   Researchers with the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute led the study and estimate that the mutation arose in the Middle East some 13,600 years ago. Only a mutation seen in cystic fibrosis that arose between 11,000 and 52,000...

2011-12-02 13:47:02

Men are three times more likely than women to develop a common form of skin cancer but medical science doesn´t know why. A new study may provide part of the answer.   Researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) have found that male mice had lower levels of an important skin antioxidant than female mice and higher levels of certain cancer-linked...

2011-09-15 20:42:39

A new study suggests that blocking cancer cells' access to cholesterol may offer a new strategy for treating glioblastoma, the most common and deadly form of brain cancer, and perhaps other malignancies. The potential treatment could be appropriate for tumors with a hyperactive PI3K signaling pathway, which accounts for up to 90 percent of glioblastomas cases. Researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove...

2011-05-16 17:30:30

Adding low doses of the targeted agent sorafenib to the chemotherapy and radiation now often used to treat head and neck cancer might significantly improve patient care and quality of life, according to a new study by researchers at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC "“ James). The findings suggest that adding sorafenib would maintain treatment efficacy while permitting the use of lower...

2011-05-10 06:30:00

CALGARY, May 10 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a Phase I study of REOLYSIN(®) alone in patients with relapsed multiple myeloma. The NCI is sponsoring the trial under its Clinical Trials Agreement with...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related